{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:25:50Z","timestamp":1777307150088,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fayoum University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This research was performed to investigate if there is a role for IL-39 in immunopathogenesis of both systemically healthy and diabetic periodontitis patients. Additionally, to explore if we can consider IL-39 and IL-35 as biomarkers for periodontitis activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>A total of 38 periodontitis patients and 19 control volunteers were included in our study. The periodontitis patients were divided equally into (Group I), 19 patients with stage III grade C periodontitis with diabetes mellitus and (Group II), 19 patients with stage III grade B periodontitis and systemically healthy. Gingival crevicular fluid levels of each interleukin were measured pre- and postoperatively for all periodontitis patients as well as control subjects using ELISA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our study results showed that the highest level for IL-39 was in diabetic periodontitis patients that decreased significantly postoperatively. However, the highest level for IL-35 was revealed in control group while the lowest value was registered in diabetic periodontitis patients and statistically increased after periodontal treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Based on the results of our research, both investigated biomarkers may have a potent role in pathogenesis of periodontitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical relevance<\/jats:title>\n                <jats:p>We could consider both interleukins as accurate diagnostic markers for periodontitis patients, regardless of diabetes mellitus association, as well as promising markers that can aid in the prevention and treatment of periodontitis patients worldwide.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00784-023-05484-3","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T02:04:41Z","timestamp":1706580281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["IL-39 and IL-35 gingival crevicular fluid levels in diabetic patients with generalized periodontitis"],"prefix":"10.1007","volume":"28","author":[{"given":"Sandy shabaan","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Abdelkawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat Gamil","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayroz Abdel Fattah","family":"Tarrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"5484_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/prd.12371","volume":"86","author":"G Hajishengallis","year":"2021","unstructured":"Hajishengallis G, Lamont RJ (2021) Polymicrobial communities in periodontal disease: their quasi-organismal nature and dialogue with the host. Periodontol 2000 86:210\u2013230. https:\/\/doi.org\/10.1111\/prd.12371","journal-title":"Periodontol 2000"},{"key":"5484_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/ccd.ccd_51_18","volume":"9","author":"SC Raj","year":"2018","unstructured":"Raj SC, Panda SM, Dash M, Patnaik K, Mohanty D, Katti N et al (2018) Association of human interleukin-35 level in gingival crevicular fluid and serum in periodontal health, disease, and after non-surgical therapy: a comparative study. Contemp Clin Dent 9:293\u2013297","journal-title":"Contemp Clin Dent"},{"key":"5484_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/prd.12451","volume":"90","author":"L Nibali","year":"2000","unstructured":"Nibali L, Gkranias N, Mainas G, Di Pino A (2000) (2022) Periodontitis and implant complications in diabetes. Periodontol 90:88\u2013105","journal-title":"Periodontol"},{"key":"5484_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/diagnostics13040681","volume":"13","author":"I P\u0103unic\u0103","year":"2023","unstructured":"P\u0103unic\u0103 I, Giurgiu M, Dumitriu AS, P\u0103unic\u0103 S, PanteaStoian AM, Martu M-A, Serafinceanu C (2023) The bidirectional relationship between periodontal disease and diabetes mellitus\u2014a review. Diagnostics 13:68. https:\/\/doi.org\/10.3390\/diagnostics13040681","journal-title":"Diagnostics"},{"key":"5484_CR5","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1007\/s00784-022-04681-w","volume":"26","author":"A Sari","year":"2022","unstructured":"Sari A, Dogan S, Nibali L, Koseoglu S (2022) Evaluation of IL-23p19\/Ebi3 (IL-39) gingival crevicular fluid levels in periodontal health, gingivitis, and periodontitis. Clin Oral Inves 26:7209\u20137218","journal-title":"Clin Oral Inves"},{"key":"5484_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/jir.2015.0015","volume":"35","author":"DV Sawant","year":"2015","unstructured":"Sawant DV, Hamilton K, Vignali DAA (2015) Interleukin-35: expanding its job profile. J Interf Cytokine Res Off J Int Soc Interf Cytokine Res 35:499\u2013512. https:\/\/doi.org\/10.1089\/jir.2015.0015","journal-title":"J Interf Cytokine Res Off J Int Soc Interf Cytokine Res"},{"key":"5484_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10753-016-0480-6","volume":"40","author":"D Hu","year":"2017","unstructured":"Hu D (2017) Role of anti-inflammatory cytokines IL-35 and IL-37 in asthma. Inflammation 40:697\u2013707","journal-title":"Inflammation"},{"key":"5484_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.13044","volume":"157","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang Y, Wang Q et al (2019) Interleukin-35 in immune-related diseases: protection or destruction. Immunology 157:13\u201320. https:\/\/doi.org\/10.1111\/imm.13044","journal-title":"Immunology"},{"issue":"5","key":"5484_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cytogfr.2015.07.003","volume":"26","author":"S Zundler","year":"2015","unstructured":"Zundler S, Neurath MF (2015) Interleukin-12: functional activities and implications for disease. Cytokine Growth Factor Rev 26(5):559\u2013568. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.07.003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"5484_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm-2016-0361","volume":"11","author":"Y Luo","year":"2017","unstructured":"Luo Y, Liu F, Liu H, Chen H, Cheng W, Dong S, Xiong W (2017) Elevated serum IL-39 in patients with ST-segment elevation myocardial infarction was related with left ventricular systolic dysfunction. Biomark Med 11(6):419\u2013426. https:\/\/doi.org\/10.2217\/bmm-2016-0361","journal-title":"Biomark Med"},{"issue":"2","key":"5484_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.5114\/ceji.2020.97911","volume":"45","author":"Z Lu","year":"2020","unstructured":"Lu Z, Xu K, Wang X, Li Y, Li M (2020) Interleukin 39: a new member of interleukin 12 family. Cent Eur J Immunol 45(2):214\u2013217. https:\/\/doi.org\/10.5114\/ceji.2020.97911","journal-title":"Cent Eur J Immunol"},{"issue":"6","key":"5484_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/eji.201546095","volume":"46","author":"X Wang","year":"2016","unstructured":"Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G, Chen G, Hou C, Ma N, Shen B, Li Y, Egwuagu CE, Wang R (2016) A novel IL23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus like mice. Eur J Immunol 46(6):1343\u20131350. https:\/\/doi.org\/10.1002\/eji.201546095","journal-title":"Eur J Immunol"},{"key":"5484_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/cei.12840","volume":"186","author":"X Wang","year":"2016","unstructured":"Wang X, Liu X, Zhang Y, Wang Z, Zhu G, Han G, Chen G, Hou C, Wang T, Ma N, Shen B, Li Y, Xiao H, Wang R (2016) Interleukin (IL)-39 [IL-23p19\/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation\/expansion of neutrophils in lupus-prone mice. Clin Exp Immunol 186:144\u2013156. https:\/\/doi.org\/10.1111\/cei.12840","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"5484_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12032-018-1236-y","volume":"36","author":"AA Manning","year":"2018","unstructured":"Manning AA, Zhao L, Zhu Z, Xiao H, Redington CG, Ding VA, Stewart-Hester T, Bai Q, Dunlap J, Wakefield MR et al (2018) IL-39 acts as a friend to pancreatic cancer. Med Oncol 36(1):12. https:\/\/doi.org\/10.1007\/s12032-018-1236-y","journal-title":"Med Oncol"},{"issue":"1","key":"5484_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/08923973.2020.1869778","volume":"43","author":"Y Li","year":"2021","unstructured":"Li Y, Gong L, Weng L, Pan X, Liu C, Li M (2021) Interleukin-39 exacerbates concanavalin A-induced liver injury. Immunopharmacol Immunotoxicol 43(1):94\u201399. https:\/\/doi.org\/10.1080\/08923973.2020.1869778","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"5484_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1601-0825.2008.01442.x","volume":"14","author":"GW Taylor","year":"2008","unstructured":"Taylor GW, Borgnakke WS (2008) Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis 14:191\u2013203","journal-title":"Oral Dis"},{"key":"5484_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12903-016-0249-1","volume":"17","author":"A Teshome","year":"2016","unstructured":"Teshome A, Yitayeh A (2016) The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: systematic review and meta-analysis. BMC Oral Health 17:31","journal-title":"BMC Oral Health"},{"key":"5484_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/jcpe.12858","volume":"45","author":"E Mauri-Obradors","year":"2018","unstructured":"Mauri-Obradors E, Merlos A, Estrugo-Devesa A, Jan\u00e9-Salas E, L\u00f3pez-L\u00f3pez J, Vi\u00f1as M (2018) Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: a randomized controlled trial. J Clin Periodontol 45:345\u2013353","journal-title":"J Clin Periodontol"},{"key":"5484_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/ccd.ccd_514_21","volume":"14","author":"RA Kolte","year":"2023","unstructured":"Kolte RA, Kolte AP, Bawankar PV, Bajaj VA (2023) Effect of nonsurgical periodontal therapy on metabolic control and systemic inflammatory markers in patients of type 2 diabetes mellitus with stage III periodontitis. Contemp Clin Dent 14:45\u201351","journal-title":"Contemp Clin Dent"},{"key":"5484_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4103\/0972-124X.106889","volume":"16","author":"S Sanikop","year":"2012","unstructured":"Sanikop S, Patil S, Agrawal P (2012) Gingival crevicular fluid alkaline phosphatase as a potential diagnostic marker of periodontal disease. J Indian Soc Periodontol 16:513\u2013518","journal-title":"J Indian Soc Periodontol"},{"key":"5484_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/molecules26051208","volume":"26","author":"T Bibi","year":"2021","unstructured":"Bibi T, Khurshid Z, Rehman A, Imran E, Srivastava KC, Shrivastava D (2021) Gingival crevicular fluid (GCF): a diagnostic tool for the detection of periodontal health and diseases. Molecules 26:1208. https:\/\/doi.org\/10.3390\/molecules26051208","journal-title":"Molecules"},{"issue":"Suppl 1","key":"5484_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/JPER.18-0157","volume":"89","author":"JG Caton","year":"2018","unstructured":"Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS (2018) A new classification scheme for periodontal and periimplant diseases and conditions\u2014introduction and key changes from the 1999 classification. J Periodontol 89(Suppl 1):S1\u2013S8. https:\/\/doi.org\/10.1002\/JPER.18-0157","journal-title":"J Periodontol"},{"issue":"1","key":"5484_CR23","first-page":"S159","volume":"89","author":"MS Tonetti","year":"2018","unstructured":"Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol 89(1):S159\u2013S172","journal-title":"J Periodontol"},{"key":"5484_CR24","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2). (2015) Classification and diagnosis of diabetes. Diabetes Care 38:S8-S16","DOI":"10.2337\/dc15-S005"},{"issue":"4","key":"5484_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.amepre.2020.11.003","volume":"60","author":"MPH Di Zhu","year":"2021","unstructured":"Di Zhu MPH, Zhao Gang, Wang Xia (2021) Association of smoking and smoking cessation with overall and cause-specific mortality. Am J Prev Med 60(4):504\u2013512","journal-title":"Am J Prev Med"},{"key":"5484_CR26","doi-asserted-by":"crossref","unstructured":"Silness J, loe H (1964) Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22:121\u2013135","DOI":"10.3109\/00016356408993968"},{"issue":"6","key":"5484_CR27","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1902\/jop.1967.38.6.610","volume":"38","author":"H Loe","year":"1967","unstructured":"Loe H (1967) The gingival index, the plaque index and the retention index systems. J Periodontol 38(6):610\u2013616","journal-title":"J Periodontol"},{"key":"5484_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-0765.1967.tb01887","volume":"2","author":"L Glavind","year":"1967","unstructured":"Glavind L, L\u00f6e H (1967) Errors in the clinical assessment of periodontal destruction. J Period Res 2:180\u2013184. https:\/\/doi.org\/10.1111\/j.1600-0765.1967.tb01887","journal-title":"J Period Res"},{"key":"5484_CR29","unstructured":"Caton J (1989) Periodontal diagnosis and diagnostic aids in proceedings of the world workshop in clinical periodontics. The American academy of periodontology, Chicago"},{"key":"5484_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.archoralbio.2017.12.022","volume":"87","author":"NA Ghallab","year":"2018","unstructured":"Ghallab NA (2018) Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: review of the current evidence. Arch Oral Biol 87:115\u2013124","journal-title":"Arch Oral Biol"},{"key":"5484_CR31","doi-asserted-by":"crossref","unstructured":"Goswamy A, Hans M, Hans VM, Sheokand V, Grover HS (2022) Effect of nonsurgical periodontal therapy on gingival crevicular fluid levels of Interleukin-35 in patients with periodontitis. J Oral Biol Craniofac Res 12:268\u2013272","DOI":"10.1016\/j.jobcr.2022.03.006"},{"issue":"84","key":"5484_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/prd.12331","volume":"2000","author":"G Hajishengallis","year":"2020","unstructured":"Hajishengallis G, Chavakis T, Lambris JD (2020) Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 2000(84):14\u201334. https:\/\/doi.org\/10.1111\/prd.12331","journal-title":"Periodontol"},{"key":"5484_CR33","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.3892\/etm.2017.5255","volume":"14","author":"Y Jin","year":"2017","unstructured":"Jin Y, Liu D, Lin X (2017) IL-35 may maintain homeostasis of the immune microenvironment in periodontitis. Exp Ther Med 14:5605\u20135610. https:\/\/doi.org\/10.3892\/etm.2017.5255","journal-title":"Exp Ther Med"},{"key":"5484_CR34","doi-asserted-by":"publisher","unstructured":"Jing L, Kim S, Sun L, Wang L, Mildner E, Divaris K, \u2026, Offenbacher S (2019) IL-37- and IL-35\/IL-37-producing plasma cells in chronic periodontitis. J Dent Res 98:813\u2013821. https:\/\/doi.org\/10.1177\/0022034519847443","DOI":"10.1177\/0022034519847443"},{"key":"5484_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10753-018-0938-9","volume":"42","author":"S Shindo","year":"2019","unstructured":"Shindo S, Hosokawa Y, Hosokawa I, Shiba H (2019) Interleukin (IL)-35 suppresses IL-6 and IL-8 production in IL-17A-stimulated human periodontal ligament cells. Inflammation 42:835\u2013840. https:\/\/doi.org\/10.1007\/s10753-018-0938-9","journal-title":"Inflammation"},{"issue":"6","key":"5484_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/jcpe.13282","volume":"47","author":"EA Cafferata","year":"2020","unstructured":"Cafferata EA, Terraza-Aguirre C, Barrera R, Faundez N, Gonzalez N, Rojas C, Melgar-Rodriguez S, Hernandez M, Carvajal P, Cortez C (2020) Interleukin-35 inhibits alveolar bone resorption by modulating the Th17\/Treg imbalance during periodontitis. J Clin Periodontol 47(6):676\u2013688","journal-title":"J Clin Periodontol"},{"key":"5484_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12903-021-01515-1","volume":"21","author":"PR Schmidlin","year":"2021","unstructured":"Schmidlin PR, Dehghannejad M, Fakheran O (2021) Interleukin-35 pathobiology in periodontal disease: a systematic scoping review. BMC Oral Health 21:139. https:\/\/doi.org\/10.1186\/s12903-021-01515-1","journal-title":"BMC Oral Health"},{"issue":"8","key":"5484_CR38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1902\/jop.2015.140666","volume":"86","author":"S Koseo\u011flu","year":"2015","unstructured":"Koseo\u011flu S, Sa\u011flam M, Pekba\u011fr\u0131yan\u0131k T, Savran L, Sutcu R (2015) Level of interleukin-35 in gingival crevicular fluid, saliva, and plasma in periodontal disease and health. J Periodontol 86(8):964\u2013967","journal-title":"J Periodontol"},{"key":"5484_CR39","unstructured":"Thakare KS, Bhongade ML, Jaiswal P, Charde P (2017) A comparative evaluation of gingival crevicular fluid (GCF) level of interleukin-35 in chronic gingivitis patients and periodontally healthy subjects. GJRA 6:(3). ISSN no. 2277\u20138160"},{"issue":"2","key":"5484_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5005\/jp-journals-10051-0089","volume":"5","author":"TS Kaustubh","year":"2017","unstructured":"Kaustubh TS, Manohar BL, Charde P, Jaiswal P (2017) Comparative evaluation of interleukin-35 levels in gingival crevicular fluid in patients with chronic gingivitis and chronic periodontitis. Int J Oral Care Res 5(2):83\u201386","journal-title":"Int J Oral Care Res"},{"key":"5484_CR41","doi-asserted-by":"publisher","unstructured":"Thakare KS, Charde PA, Bhongade ML, Jaiswal PP, Bajaj PS (2022) Evaluation of gingival crevicular fluid interleukin-35 as a marker for identification of periodontal disease activity. Minerva Dent Oral Sci 71(6):346\u2013352. https:\/\/doi.org\/10.23736\/S2724-6329.22.04425-4","DOI":"10.23736\/S2724-6329.22.04425-4"},{"key":"5484_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1155\/2013\/489648","volume":"35","author":"NB Kalburgi","year":"2012","unstructured":"Kalburgi NB, Muley A, Shivaprasad BM, Koregol AC (2012) Expression profile of IL-35 mRNA in gingiva of chronic periodontitis and aggressive periodontitis patients: a semiquantitative RT-PCR study. Dis Markers 35:819\u2013823. https:\/\/doi.org\/10.1155\/2013\/489648","journal-title":"Dis Markers"},{"issue":"2","key":"5484_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1902\/jop.2014.140293","volume":"86","author":"A Mitani","year":"2015","unstructured":"Mitani A, Niedbala W, Fujimura T, Mogi M, Miyamae S, Higuchi N, Abe A, Hishikawa T, Mizutani M, Ishihara Y (2015) Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis. J Periodontol 86(2):301\u2013309","journal-title":"J Periodontol"},{"key":"5484_CR44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12903-015-0073-z","volume":"15","author":"HG Mohamed","year":"2015","unstructured":"Mohamed HG, Idris SB, Ahmed MF, \u00c5str\u00f8m AN, Mustafa K, Ibrahim SO, Mustafa M (2015) Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional study. BMC Oral Health 15:86","journal-title":"BMC Oral Health"},{"issue":"3","key":"5484_CR45","first-page":"295","volume":"10","author":"A Maboudi","year":"2019","unstructured":"Maboudi A, Eghbalian-Nouzanizadeh A, Seifi H, Bahar A, Heidari M, Mohammadpour RA et al (2019) Serum levels of interleukin-23 and 35 in patients with and without type 2 diabetes mellitus and chronic periodontitis. Caspian J Intern Med 10(3):295\u2013302","journal-title":"Caspian J Intern Med"},{"issue":"9","key":"5484_CR46","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.4103\/njcp.njcp_51_18","volume":"21","author":"K Ustun","year":"2018","unstructured":"Ustun K, Hatipo\u011flu M, Daltaban O, Felek R, Firat M (2018) Clinical and biochemical effects of erbium, chromium: yttrium, scandium, gallium, garnet laser treatment as a complement to periodontal treatment. Niger J Clin Pract 21(9):1150\u20131157","journal-title":"Niger J Clin Pract"},{"issue":"2","key":"5484_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.26715\/rjds.13_2_5","volume":"13","author":"A Varghese","year":"2018","unstructured":"Varghese A, Babu HM, Naik AR, Savita AM, Kukkera PN (2018) Gingival crevicular fluid levels of interleukin-35 in periodontal health, chronic periodontitis & the effect of scaling & root planing on interleukin-35 levels in chronic periodontitis \u2013 a randomized controlled clinical study. RGUHS Journal of Dental Sciences 13(2):7\u201315","journal-title":"RGUHS Journal of Dental Sciences"},{"key":"5484_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102430","volume":"46","author":"MG Yang","year":"2020","unstructured":"Yang MG, Tian S, Zhang Q, Han J, Liu C, Zhou Y, Zhu J, Jin T (2020) Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity. Mult Scler Relat Disord 46:102430. https:\/\/doi.org\/10.1016\/j.msard.2020.102430","journal-title":"Mult Scler Relat Disord"},{"key":"5484_CR49","doi-asserted-by":"publisher","unstructured":"Nussrat SW, Adhiah AH (2023) Interleukin-39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index. Endocrinol Diabetes Metab 6(3):e409. https:\/\/doi.org\/10.1002\/edm2.409","DOI":"10.1002\/edm2.409"},{"issue":"1","key":"5484_CR50","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3892\/mmr.2017.8048","volume":"17","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang Y, Wang Z, Liu X, Zhu G, Han G, Chen G, Hou C, Wang T, Shen B et al (2018) AntiIL39 (IL23p19\/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus like mice. Mol Med Rep 17(1):1660\u20131666. https:\/\/doi.org\/10.3892\/mmr.2017.8048","journal-title":"Mol Med Rep"},{"key":"5484_CR51","doi-asserted-by":"crossref","unstructured":"Pal D, Nasim F, Chakrabarty H, Chakraborty A (2021) Non surgical periodontal therapy: an evidence-based perspective. J Dent Panacea 3(2):1\u20134","DOI":"10.18231\/j.jdp.2021.012"},{"key":"5484_CR52","doi-asserted-by":"crossref","unstructured":"Mani A, Sachdeva S, Mani S, Gaydhani M, Pawar H (2023) Effect of non-surgical periodontal therapy on gingival parameters of diabetic and non-diabetic periodontitis patients: a prospective clinical study. J Clin Diagnostic Res 17(5):21\u201325. 5p","DOI":"10.7860\/JCDR\/2023\/62528.17986"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-05484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-023-05484-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-023-05484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:13:11Z","timestamp":1709244791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-023-05484-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["5484"],"URL":"https:\/\/doi.org\/10.1007\/s00784-023-05484-3","relation":{},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2022 This study was approved by the Research Ethics Committee of the Faculty of Dentistry, Beni-Suef University (approval number: REC-FDBSU\/06102022\u201302\/HS).\u2022 The clinical trial was registered in the U.S. National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov: NCT05880654).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The enrolled patients provided informed consent following the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}